Presentation is loading. Please wait.

Presentation is loading. Please wait.

Volume 60, Issue 2, Pages (August 2011)

Similar presentations


Presentation on theme: "Volume 60, Issue 2, Pages (August 2011)"— Presentation transcript:

1 Volume 60, Issue 2, Pages 366-373 (August 2011)
Renal Cell Carcinoma (RCC) in Patients With End-Stage Renal Disease Exhibits Many Favourable Clinical, Pathologic, and Outcome Features Compared With RCC in the General Population  Yann Neuzillet, Xavier Tillou, Romain Mathieu, Jean-Alexandre Long, Marc Gigante, Philippe Paparel, Laura Poissonnier, Hervé Baumert, Bernard Escudier, Hervé Lang, Nathalie Rioux-Leclercq, Pierre Bigot, Jean-Christophe Bernhard, Laurence Albiges, Laurence Bastien, Jacques Petit, Fabien Saint, Franck Bruyere, Jean-Michel Boutin, Nicolas Brichart, Georges Karam, Julien Branchereau, Jean- Marie Ferriere, Hervé Wallerand, Sébastien Barbet, Hicham Elkentaoui, Jacques Hubert, Benoit Feuillu, Pierre-Etienne Theveniaud, Arnauld Villers, Laurent Zini, Aurélien Descazeaux, Morgan Roupret, Benoit Barrou, Karim Fehri, Thierry Lebret, Jacques Tostain, Jean- Etienne Terrier, Nicolas Terrier, Lucille Martin, Fabrice Dugardin, Ismaël Galliot, Frédéric Staerman, Marie-Dominique Azemar, Jacques Irani, Baptiste Tisserand, Marc-Olivier Timsit, Federico Sallusto, Pascal Rischmann, Laurent Guy, Antoine Valeri, Charles Deruelle, Abdel-Rahmène Azzouzi, Denis Chautard, Arnaud Mejean, Laurent Salomon, Jérôme Rigaud, Christian Pfister, Michel Soulié, François Kleinclauss, Lionel Badet, Jean-Jacques Patard  European Urology  Volume 60, Issue 2, Pages (August 2011) DOI: /j.eururo Copyright © 2011 European Association of Urology Terms and Conditions

2 Fig. 1 Comparison of renal cell carcinoma (RCC)–specific survival time for end-stage renal disease (ESRD) and non-ESRD patients. European Urology  , DOI: ( /j.eururo ) Copyright © 2011 European Association of Urology Terms and Conditions

3 Fig. 2 Comparison of renal cell carcinoma (RCC)–specific survival time stratified by histologic subtype (a) for clear cell RCCs arising in end-stage renal disease (ESRD) and non-ESRD patients and (b) for papillary RCCs arising in ESRD and non-ESRD patients. European Urology  , DOI: ( /j.eururo ) Copyright © 2011 European Association of Urology Terms and Conditions


Download ppt "Volume 60, Issue 2, Pages (August 2011)"

Similar presentations


Ads by Google